Medical Devices

As Nanobiotix joins Europe's tech elite, its nanotech cancer therapy gains a powerful spotlight, signaling a new era for physics-based medicine.

Beyond robots, Compal and NVIDIA are building the digital nervous system for healthcare, leveraging Taiwan's unique tech ecosystem to turn hospitals into smart organisms.

Revance unites its top acne treatment, PanOxyl, and microneedling device, SkinPen, in a strategic play to capture the holistic skincare market.

MedtechWOMEN's VISION 2026 conference will address the industry's most pressing challenges, featuring leaders like Dr. Bayo Curry-Winchell and Martha Aronson.

With $12M in new funding, Veritas Aortic Solutions aims to replace high-risk open-heart surgery with a groundbreaking transcatheter device for the aorta.

Facing delisting, biotech firm Cuprina Holdings executes a reverse split and appeals to Nasdaq. Will the high-stakes gamble pay off for the company?

SurGenTec's FDA clearance for its ION-C™ system, now compatible with Medtronic navigation, signals a new era of precision in cervical spine surgery.

Meet the Austin trio behind Alafair Biosciences, whose innovative hydrogel technology is transforming surgical recovery and earning them top entrepreneurial honors.

A new AI platform using smartwatches just got FDA's Breakthrough nod, promising to predict heart failure crises before they happen from home.

A new partnership aims to deploy AI-powered imaging and advanced training across Asia Pacific, tackling the region's leading cause of death head-on.

A new manufacturing deal positions ViCentra to serve thousands more diabetes patients in Europe and sets the stage for a future U.S. market challenge.

A Tulsa jury found a doctor negligent, awarding $15M to a girl left with severe brain damage after a missed diagnosis of bacterial meningitis as an infant.

Groundbreaking research on new drug classes, the gut-brain axis, and personalized medicine will be unveiled at the upcoming American Headache Society meeting.

A fivefold increase in one year, THINK Surgical’s miniature robot is reshaping orthopedics with its unique open platform and powerful industry partnerships.

Therini Bio's novel drug THN391 enters trials, targeting inflammation in diabetic eye disease, while a next-gen combo therapy aims to redefine care.

With backing from GV and Dexcom, Signos is using AI and OTC glucose monitors to offer a new path for sustainable weight management beyond GLP-1 drugs.

The cold storage giant's strategic acquisition of a pharma-certified specialist signals a major shift into the high-stakes world of medical logistics.

With late-stage trials for its revolutionary eye and lung disease treatments, 4DMT must convince investors its focused, high-stakes strategy will pay off.

New preclinical data shows RTY-406 could be a first-in-class therapy for PSC, a progressive liver disease with no effective treatments.

Vanda Pharmaceuticals' rare disease drug gets a key designation in Japan, unlocking major incentives and promising a new treatment for a severe skin disease.